Full Archive

Better to be lucky than good

The stock is up nearly 70% over the past 12 months, there is so much demand for the products you sell that you can’t make it fast enough, better still demand will only increase as this product is finding even more uses. Want more good news reimbursement is improving too. As Momma Kliff would say this is an embarrassment of riches. This embarrassment of riches also has another benefit as it...

No problem finding study participants

According to a study published in Phytotherapy Research those who consume cannabis are half as likely to develop type 2 diabetes as those who don’t. The authors concluded – “A protective effect of cannabis consumption on the odds of diabetes mellitus type 2 development has been suggested. Yet given the considerable interstudy heterogeneity, the upward trend of cannabis consumption and cannabis legalization is recommended to conduct studies with higher levels of...

Crazy like a fox

When we were the first to report that Abbott was considering selling their diabetes franchise, we honestly believed this was one of the rumors that started around the water cooler got overheard and off it went. Well, it seems this is no longer a rumor but an actual albeit remote possibility. It seems Mr. Ford Abbott CEO is willing to part with his baby as he feels his baby is...

The Ozempic Effect

It happened again during the Medtronic the now standard question on how GLP-1 therapies such as Ozempic and Mounjaro are impacting the diabetes tech market. Geoff Martha CEO gave a pretty good answer basically saying there is no impact in Type 1 diabetes. Which is 100% accurate but that hasn’t changed the widely held perception that these therapies will crush diabetes tech companies. Pure diabetes tech companies have seen their shares...

Payback is a ….

This morning Medtronic reported first quarter results which indicated the 780G is doing what we thought it would and keeping patients in the Medtronic fold. The system which has received positive user reviews has placed the company’s main competitor Tandem in an even more difficult position. While this isn’t related to the results Tandem announced Brian B. Hansen, EVP and CCO, notified the company of his decision to resign on...

Taking Wackiness to new heights

Just when you think you have seen or heard it all something completely wacky comes out of nowhere that stuns you. This happened to me over the weekend when I heard perhaps the wackiest rumor ever and that’s saying something given, I’ve been doing this almost 30 years. It seems that troops at Abbott Diabetes Care believe the division is about to be sold. That Robert Ford Abbott CEO would...

The Arms Race Continues

It wasn’t that long ago that the USA and USSR engaged in a race to build the largest nuclear arms arsenal. Back in the day many of us became familiar with the term mutually assured destruction. Thankfully those days have passed and have now moved into our wacky world only it’s not the USA vs USSR but Novo Nordisk vs Lilly. Just this morning Novo made the following announcement- “Novo Nordisk...